标普生物科技LOF(161127)
动态评分： 5.92分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2021-12-31 | ALEC | Alector Inc | 77.38 | 0.51% |
| 2021-12-31 | DMTK | DermTech Inc | 75.12 | 0.5% |
| 2021-12-31 | CLVS | Clovis Oncology Inc | 75.38 | 0.5% |
| 2021-12-31 | ENTA | Enanta Pharmaceuticals Inc | 74.9 | 0.49% |
| 2021-12-31 | GTHX | G1 Therapeutics Inc | 73.73 | 0.49% |
| 2021-12-31 | MNKD | 曼恩凯德生物医疗 | 73.7 | 0.49% |
| 2021-12-31 | ORGO | Organogenesis Holdings Inc-A | 73.93 | 0.49% |
| 2021-12-31 | SNDX | Syndax Pharmaceuticals Inc | 72.08 | 0.48% |
| 2021-12-31 | GRTS | Gritstone bio Inc | 71.59 | 0.47% |
| 2021-12-31 | ALT | Altimmune Inc | 69.71 | 0.46% |
| 2021-12-31 | RAPT | RAPT Therapeutics Inc | 64.8 | 0.43% |
| 2021-12-31 | MDGL | Madrigal Pharmaceuticals Inc | 64.94 | 0.43% |
| 2021-12-31 | RCKT | Rocket Pharmaceuticals Inc | 65.78 | 0.43% |
| 2021-12-31 | SANA | Sana Biotechnology Inc | 63.99 | 0.42% |
| 2021-12-31 | QURE | uniQure NV | 63.96 | 0.42% |
| 2021-12-31 | IMGN | ImmunoGen Inc | 63.62 | 0.42% |
| 2021-12-31 | CCCC | C4 Therapeutics Inc | 62.12 | 0.41% |
| 2021-12-31 | KURA | Kura Oncology Inc | 59.95 | 0.4% |
| 2021-12-31 | CRIS | 居里 | 59.2 | 0.39% |
| 2021-12-31 | CHRS | Coherus BioSciences Inc | 59.67 | 0.39% |
公告&资料
